Table: begin end state 1 26 cytoplasmic 27 52 transmembrane 53 60 non-cytoplasmic 61 82 transmembrane 83 93 cytoplasmic 94 113 transmembrane 114 118 non-cytoplasmic 119 140 transmembrane 141 151 cytoplasmic 152 172 transmembrane 173 184 non-cytoplasmic 185 205 transmembrane 206 266 cytoplasmic 267 290 transmembrane 291 302 non-cytoplasmic 303 326 transmembrane 327 333 cytoplasmic 334 357 transmembrane 358 369 non-cytoplasmic 370 395 transmembrane 396 406 cytoplasmic 407 427 transmembrane 428 428 non-cytoplasmic 429 455 transmembrane 456 483 cytoplasmic
Input: >WP_084931296.1 NCBI__GCF_002095475.1:WP_084931296.1 MEKELYISTNTASGPNSVTRTEPFVKIIALVATLGGLLFGYDTGVVSGALLFMRDDLQLT PFTTGLVTSSLLFGAAFGALLAGHFADAMGRRKIIIMLAFIFALGAVGSAFAPDVVSMIV SRLFLGIAVGGAAATVPVYIAEIAPANKRGQLVTLQELMIVSGQLLAYVSNATFNEIWGG EHTWRWMLAISTVPAVLLWLGMIFMPESPRWHVMRGNTGEARKVLEKTRAADDVEWELEE IEETIEENRQKGKGRLRDLKTPWLRKVFLLGIGIAAIQQLTGVNTIMYYAPTMLTATGLS NDAALFATIANGVISVLMTLVGIWMIGKIGRRPLVLVGQMGCTACLFFIAAVCFFMPEYH VGGEVNLVRAYLVLTGMLMFLCFQQGALSPVTWLLLSEIFPARLRGICMGGAVFALWMAN FAISMAFPILLAAFGLAGAFLAFAIIGIGGSMFVLRTIPETRGRSLEQIEHYFYELYDGK PSR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server